Pei-Jane Tsai

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Infectious Diseases

Top Venues

International journal of molecular sciences

Infection and drug resistance

Antibiotics (Basel, Switzerland)

Veterinary sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Bo-Yang Tsai, Pei-Jane Tsai, Ching-Chih Lee, Chun-Wei Chiu, Yi-Hsin Lai, Jen-Chieh Lee, Wen-Chien Ko, Yuan-Pin Hung
Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection. Infection and drug resistance 16 (2023)
Cherng-Shyang Chang, Shang-Shiuan Yu, Li-Chun Ho, Shu-Hsin Chao, Ting-Yu Chou, Ai-Ning Shao, Ling-Zhen Kao, Chia-Yu Chang, Yu-Hsin Chen, Ming-Shan Wu, Pei-Jane Tsai, Nobuyo Maeda, Yau-Sheng Tsai
Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. International journal of molecular sciences 24 (4) (2023)
Cherng-Shyang Chang, Shang-Shiuan Yu, Li-Chun Ho, Shu-Hsin Chao, Ting-Yu Chou, Ai-Ning Shao, Ling-Zhen Kao, Chia-Yu Chang, Yu-Hsin Chen, Ming-Shan Wu, Pei-Jane Tsai, Nobuyo Maeda, Yau-Sheng Tsai
Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. International journal of molecular sciences 24 (4) (2023)
Cherng-Shyang Chang, Shang-Shiuan Yu, Li-Chun Ho, Shu-Hsin Chao, Ting-Yu Chou, Ai-Ning Shao, Ling-Zhen Kao, Chia-Yu Chang, Yu-Hsin Chen, Ming-Shan Wu, Pei-Jane Tsai, Nobuyo Maeda, Yau-Sheng Tsai
Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. International journal of molecular sciences 24 (4) (2023)
Cherng-Shyang Chang, Shang-Shiuan Yu, Li-Chun Ho, Shu-Hsin Chao, Ting-Yu Chou, Ai-Ning Shao, Ling-Zhen Kao, Chia-Yu Chang, Yu-Hsin Chen, Ming-Shan Wu, Pei-Jane Tsai, Nobuyo Maeda, Yau-Sheng Tsai
Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. International journal of molecular sciences 24 (4) (2023)
Bo-Yang Tsai, Pei-Jane Tsai, Ching-Chih Lee, Chun-Wei Chiu, Yi-Hsin Lai, Jen-Chieh Lee, Wen-Chien Ko, Yuan-Pin Hung
Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection. Infection and drug resistance 16 (2023)
Cherng-Shyang Chang, Shang-Shiuan Yu, Li-Chun Ho, Shu-Hsin Chao, Ting-Yu Chou, Ai-Ning Shao, Ling-Zhen Kao, Chia-Yu Chang, Yu-Hsin Chen, Ming-Shan Wu, Pei-Jane Tsai, Nobuyo Maeda, Yau-Sheng Tsai
Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. International journal of molecular sciences 24 (4) (2023)
Bo-Yang Tsai, Yi-Hsin Lai, Chun-Wei Chiu, Chih-Yu Hsu, Yi-Hsuan Chen, Yueh-Lin Chen, Pei-Jane Tsai, Yuan-Pin Hung, Wen-Chien Ko
Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice. Antibiotics (Basel, Switzerland) 11 (1) (2022)
Hui-Wen Lin, Meilin Wang, Pei-Jane Tsai, Yi-Ju Lee, Ming-Chang Hsieh, Dah-Yuu Lu, Wei-Li Hsu, Ming-Shiou Jan, Yuan-Yen Chang
The Establishment of a Noninvasive Bioluminescence-Specific Viral Encephalitis Model by Pseudorabies Virus-Infected NF-κBp-Luciferase Mice. Veterinary sciences 9 (3) (2022)
Ching-Chih Lee, Chun-Wei Chiu, Jen-Chieh Lee, Pei-Jane Tsai, Wen-Chien Ko, Yuan-Pin Hung
Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection. Infection and drug resistance 15 (2022)
Yuan-Pin Hung, Jen-Chieh Lee, Chun-Wei Chiu, Ching-Chi Lee, Pei-Jane Tsai, I-Lin Hsu, Wen-Chien Ko
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark? Antibiotics (Basel, Switzerland) 11 (2) (2022)
Yuan-Pin Hung, Yu-Fon Chen, Pei-Jane Tsai, I-Hsiu Huang, Wen-Chien Ko, Jeng-Shiung Jan
Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases. Pharmaceutics 13 (11) (2021)